Neumora Therapeutics, Inc.盘中异动早盘股价大跌5.28%报15.62美元

市场透视10-21

北京时间2024年10月21日21时30分，Neumora Therapeutics, Inc.（NMRA.us）股票出现异动，股价急速跳水5.28%。截至发稿，该股报15.62美元/股，成交量3.6157万股，换手率0.02%，振幅0.79%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-58.70百万美元，每股收益-0.37美元，毛利-160000.00美元，市盈率-9.27倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2477823865?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-21 21:30","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2477823865","market":"us","top_or_hot":-1,"title":"Neumora Therapeutics, Inc.盘中异动 早盘股价大跌5.28%报15.62美元","media":"市场透视","content":"<div>\n<p>北京时间2024年10月21日21时30分，Neumora Therapeutics, Inc.（NMRA.us）股票出现异动，股价急速跳水5.28%。截至发稿，该股报15.62美元/股，成交量3.6157万股，换手率0.02%，振幅0.79%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-58.70百万美元，每股收益-0.37美元，毛利-160000.00美元，市盈率-9.27倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213055971a15af&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Neumora Therapeutics, Inc.盘中异动 早盘股价大跌5.28%报15.62美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNeumora Therapeutics, Inc.盘中异动 早盘股价大跌5.28%报15.62美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-21 21:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213055971a15af&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年10月21日21时30分，Neumora Therapeutics, Inc.（NMRA.us）股票出现异动，股价急速跳水5.28%。截至发稿，该股报15.62美元/股，成交量3.6157万股，换手率0.02%，振幅0.79%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-58.70百万美元，每股收益-0.37美元，毛利-160000.00美元，市盈率-9.27倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213055971a15af&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213055971a15af&s=b","article_id":"2477823865","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213055971a15af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2477823865","pubTimestamp":1729517455,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年10月21日21时30分，Neumora Therapeutics, Inc.股票出现异动，股价急速跳水5.28%。截至发稿，该股报15.62美元/股，成交量3.6157万股，换手率0.02%，振幅0.79%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","LENZ":"Therapeutics","NMRA":"Neumora Therapeutics, Inc.","BK4007":"制药"},"translate_title":"Neumora Therapeutics, Inc. shares fell 5.28% to $15.62 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"NMRA":1},"content_text":"北京时间2024年10月21日21时30分，Neumora Therapeutics, Inc.（NMRA.us）股票出现异动，股价急速跳水5.28%。截至发稿，该股报15.62美元/股，成交量3.6157万股，换手率0.02%，振幅0.79%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-58.70百万美元，每股收益-0.37美元，毛利-160000.00美元，市盈率-9.27倍。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Gri Bio, Inc.、Biovie Inc.、Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)涨幅较大，Gri Bio, Inc.、Genprex, Inc.、Biovie Inc.较为活跃，换手率分别为1731.03%、538.29%、301.00%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025(To Pur Com)、Virpax Pharmaceuticals, Inc.、Oculis Holding Ag，振幅分别为34.19%、7.97%、5.77%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。 它已经迅速扩大了其治疗管道，目前由七个临床和临床前神经科学项目组成，这些项目针对广泛的服务不足的神经精神疾病和神经退行性疾病的新作用机制。 该公司预计将继续推进其管道的开发，计划在未来 12 至 18 个月内启动多个项目的临床试验，这支持大量预期的数据读出。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2477823865"}

Neumora Therapeutics, Inc.盘中异动 早盘股价大跌5.28%报15.62美元

精彩评论

Neumora Therapeutics, Inc.盘中异动早盘股价大跌5.28%报15.62美元